| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 20.38B | 20.10B | 18.02B | 18.61B | 18.82B | 14.59B |
| Gross Profit | 9.07B | 8.93B | 7.56B | 7.31B | 7.60B | 5.80B |
| EBITDA | 3.43B | 3.29B | 2.18B | 2.06B | 2.21B | 577.11M |
| Net Income | 1.75B | 1.72B | 786.58M | 645.42M | 47.09M | 750.57M |
Balance Sheet | ||||||
| Total Assets | 26.68B | 26.82B | 26.12B | 25.58B | 26.90B | 28.19B |
| Cash, Cash Equivalents and Short-Term Investments | 5.71B | 6.01B | 5.07B | 4.11B | 3.75B | 7.23B |
| Total Debt | 1.26B | 525.82M | 1.23B | 1.76B | 1.74B | 2.79B |
| Total Liabilities | 4.96B | 4.20B | 4.82B | 4.60B | 6.33B | 7.51B |
| Stockholders Equity | 21.73B | 22.62B | 21.30B | 20.98B | 20.57B | 20.68B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 2.34B | 2.35B | 1.40B | -2.88B | -4.25B |
| Operating Cash Flow | 0.00 | 2.76B | 2.63B | 2.41B | 289.63M | 87.25M |
| Investing Cash Flow | 0.00 | -529.65M | -541.01M | -1.17B | -2.28B | -4.40B |
| Financing Cash Flow | 0.00 | -1.30B | -1.47B | -718.34M | -1.55B | 3.21B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | ¥11.01B | 27.33 | ― | 4.76% | 41.13% | 535.42% | |
72 Outperform | ¥83.84B | 137.67 | ― | 2.16% | -8.71% | -17.77% | |
70 Outperform | ¥134.62B | 7.70 | 8.17% | 2.04% | 1.48% | 58.59% | |
70 Outperform | ¥67.96B | 4.09 | ― | 3.09% | 6.35% | -34.20% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
61 Neutral | ¥33.08B | 25.47 | ― | 2.53% | 6.56% | 23.98% | |
56 Neutral | ¥12.42B | -14.04 | ― | 5.25% | -6.68% | -28.64% |